Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,543 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacological characterisation of a rat model of incisional pain.
Whiteside GT, Harrison J, Boulet J, Mark L, Pearson M, Gottshall S, Walker K. Whiteside GT, et al. Among authors: walker k. Br J Pharmacol. 2004 Jan;141(1):85-91. doi: 10.1038/sj.bjp.0705568. Epub 2003 Nov 3. Br J Pharmacol. 2004. PMID: 14597606 Free PMC article.
N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: II. in vivo characterization in rat models of inflammatory and neuropathic pain.
Pomonis JD, Harrison JE, Mark L, Bristol DR, Valenzano KJ, Walker K. Pomonis JD, et al. Among authors: walker k. J Pharmacol Exp Ther. 2003 Jul;306(1):387-93. doi: 10.1124/jpet.102.046268. Epub 2003 Apr 29. J Pharmacol Exp Ther. 2003. PMID: 12721336
DiPOA ([8-(3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]-acetic acid), a novel, systemically available, and peripherally restricted Mu opioid agonist with antihyperalgesic activity: II. In vivo pharmacological characterization in the rat.
Whiteside GT, Harrison JE, Pearson MS, Chen Z, Fundytus ME, Rotshteyn Y, Turchin PI, Pomonis JD, Mark L, Walker K, Broglé KC. Whiteside GT, et al. Among authors: walker k. J Pharmacol Exp Ther. 2004 Aug;310(2):793-9. doi: 10.1124/jpet.103.063560. Epub 2004 Mar 30. J Pharmacol Exp Ther. 2004. PMID: 15054116
A rat model of bone cancer pain.
Medhurst SJ, Walker K, Bowes M, Kidd BL, Glatt M, Muller M, Hattenberger M, Vaxelaire J, O'Reilly T, Wotherspoon G, Winter J, Green J, Urban L. Medhurst SJ, et al. Among authors: walker k. Pain. 2002 Mar;96(1-2):129-40. doi: 10.1016/s0304-3959(01)00437-7. Pain. 2002. PMID: 11932069
Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function. I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain.
Walker K, Bowes M, Panesar M, Davis A, Gentry C, Kesingland A, Gasparini F, Spooren W, Stoehr N, Pagano A, Flor PJ, Vranesic I, Lingenhoehl K, Johnson EC, Varney M, Urban L, Kuhn R. Walker K, et al. Neuropharmacology. 2001;40(1):1-9. doi: 10.1016/s0028-3908(00)00113-1. Neuropharmacology. 2001. PMID: 11077065
2,543 results